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introduction: Lung cancer patients receiving radiotherapy present with acute esopha-
gitis and chronic fibrosis, as a result of radiation injury to esophageal tissues. We have 
shown that soy isoflavones alleviate pneumonitis and fibrosis caused by radiation toxicity 
to normal lung. The effect of soy isoflavones on esophagitis histopathological changes 
induced by radiation was investigated.
Methods: C57BL/6 mice were treated with 10 Gy or 25 Gy single thoracic irradiation 
and soy isoflavones for up to 16 weeks. Damage to esophageal tissues was assessed 
by hematoxylin–eosin, Masson’s Trichrome and Ki-67 staining at 1, 4, 10, and 16 weeks 
after radiation. The effects on smooth muscle cells and leukocyte infiltration were deter-
mined by immunohistochemistry using anti-αSMA and anti-CD45, respectively.
results: Radiation caused thickening of esophageal tissue layers that was significantly 
reduced by soy isoflavones. Major radiation alterations included hypertrophy of basal 
cells in mucosal epithelium and damage to smooth muscle cells in muscularis mucosae 
as well as disruption of collagen fibers in lamina propria connective tissue with leukocyte 
infiltration. These effects were observed as early as 1 week after radiation and were more 
pronounced with a higher dose of 25 Gy. Soy isoflavones limited the extent of tissue 
damage induced by radiation both at 10 and 25 Gy.
conclusion: Soy isoflavones have a radioprotective effect on the esophagus, mitigating 
the early and late effects of radiation injury in several esophagus tissue layers. Soy could 
be administered with radiotherapy to decrease the incidence and severity of esophagitis 
in lung cancer patients receiving thoracic radiation therapy.
Keywords: radiation, soy isoflavones, esophagitis, histopathology, radioprotection
inTrODUcTiOn
Radiation-induced toxicity to normal esophageal tissue is a dose-limiting side effect of radiotherapy 
for lung cancer and head and neck cancer (1–5). Radiation-induced toxicity to the esophagus can also 
be exacerbated by the addition of one or more chemotherapeutic drugs to the radiation treatment 
(1, 3–5). Concurrent chemoradiation therapy, consisting of fractionated radiation doses of 1.8–2 Gy 
per day delivered over a period of 6–7 weeks with concurrent chemotherapy, is the standard of care 
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in patients presenting with locally advanced non-small cell lung 
cancer (NSCLC) (6, 7). Several trials have shown that concur-
rent chemotherapy with radiotherapy is superior to sequential 
chemotherapy followed by radiotherapy, achieving an absolute 
improvement in survival of 10% at 2  years (6, 7). Although, 
concurrent chemoradiation therapy results in improved survival 
outcomes, it is associated with increased toxicity, specifically 
acute esophagitis (3, 4, 8).
Esophagitis is an early side effect of radiation or chemoradia-
tion, causing pain, difficulties in swallowing with potential mal-
nutrition and dehydration. Strictures may develop in the chronic 
phase as a result of radiation-induced fibrosis (9). Esophagitis 
presents with odynophagia (irritation and burning sensation upon 
swallowing) and dysphagia (difficulties in the function of swal-
lowing). Odynophagia symptoms usually have a rapid onset, and 
can be dose-limiting, presenting a serious challenge for radiation 
oncologists and can result in “premature” (early) termination of 
radiation treatment or breaks in therapy (3, 10–12). Odynophagia 
can be attributed to histological changes from radiation injury, 
including rapid mucosal epithelium (EPI) depletion, limited basal 
cell proliferation for epithelial repopulation, tissue inflammation, 
and tissue ulceration (12–14). Alternatively, dysphagia results 
from an acute or chronic tissue response to radiation injury and 
produces a mechanical restriction (and subsequent discomfort) 
in the action of swallowing (11, 12). Radiation Therapy Oncology 
Group (RTOG) and NCI CTCAE version 4 criteria scored acute 
esophagitis with toxicity grades as Grade 1 defined by asymp-
tomatic or mild dysphagia or odynophagia (may require topical 
anesthetic or non-narcotic analgesic, soft diet); Grade 2 with 
symptomatic esophagitis, altered eating/swallowing (may require 
narcotic analgesics, puree or liquid diet); Grade 3 with severely 
altered eating/swallowing with dehydration or weight loss (N-G 
feeding tube, TPN, i.v. fluids or hospitalization indicated); Grade 
4 with life-threatening consequences, with complete obstruction, 
ulceration, perforation, fistula, and urgent operative intervention 
if necessary (3, 10).
Analysis of RTOG trials reported that 95% of patients receiv-
ing concurrent chemoradiation for NSCLC developed some 
level of radiation esophagitis (grades 1–4) and 33% of patients 
experienced severe esophagitis (Grade ≥3) peaking within the 
first or second month of radiotherapy (3). Recent international 
meta-analysis for patients receiving concurrent chemoradiation 
reported about fivefold increase in the risk of acute radiation 
esophagitis and symptomatic radiation pneumonitis in 15–40% of 
patients compared with patients receiving sequential treatment (4, 
5). These symptoms could lead to early interruption of radiation 
treatment, limiting the efficacy of radiation therapy. Therefore, it 
is imperative to design strategies to alleviate the clinical symptoms 
of radiation-induced toxicity to the normal esophagus.
In the current study, we have investigated a complementary 
approach to radiotherapy using soy isoflavones to reduce 
esophagitis. We hypothesized that soy isoflavones could provide 
radioprotection to normal esophageal tissues from radiation-
induced tissue damage, based on our previous studies showing 
mitigation of radiation-induced pneumonitis and fibrosis by soy 
isoflavones. Soy isoflavones consist of a mixture of genistein, 
daidzein, and glycitein plant estrogens extracted from soy beans 
and are non-toxic dietary compounds that have demonstrated 
chemoprevention effects and anti-cancer properties (15). We 
have demonstrated that soy isoflavones enhance radiation-
induced cancer cell killing in vitro and in vivo in tumor models 
of prostate cancer, renal cancer, and lung cancer (16–19). In 
addition to radiosensitizing tumor cells, we have recently shown 
that soy isoflavones could also act as radioprotectants of normal 
lung tissues when given in conjunction with radiation therapy 
(19, 20). In pre-clinical studies, soy isoflavones reduced the 
extent of pneumonitis and fibrosis caused by radiation damage 
to normal lung tissue (18–20). This differential effect of soy 
isoflavones on cancer cells versus normal tissue was shown in an 
orthotopic murine model of lung cancer, demonstrating that soy 
increased radiation-induced destruction of lung tumor nodules 
while simultaneously mitigating vascular damage, inflammation, 
and fibrosis caused by radiation in normal lung tissue (18–20). 
Further studies conducted in naïve mice receiving a high dose 
of 12 Gy thoracic irradiation in conjunction with soy isoflavones 
given pre- and post-radiation, confirmed their radioprotective 
effects (20). Soy isoflavones mitigated radiation injury to skin and 
hair follicles, protected respiratory function, decreased pneumo-
nitis by limiting the thickening of alveolar septa and inflamma-
tory infiltration, and reduced the extent of lung fibrosis caused 
by radiation at late time points (20). These findings within the 
normal lung parenchyma are indicative of early and late effects 
of radiation-induced tissue injury and subsequent inflammatory 
response, and support a radioprotective role for soy isoflavones. 
As suggested by the lung studies, soy isoflavones have the capacity 
to affect multiple aspects of the inflammatory response to radia-
tion injury, and could potentially play role in alleviating tissue 
injury in other thoracic organs.
Given the potential severity of esophagitis caused by radiation 
in lung cancer patients, we have now investigated whether soy 
isoflavones could reduce the tissue damage in normal esophagus. 
These studies were conducted in naïve immunocompetent mice, 
using conditions of a single high dose of thoracic radiation at 
10 Gy or 25 Gy to detect significant tissue damage. To character-
ize the histopathological changes of radiation-induced damage 
in esophagus and investigate the effect of soy isoflavones on 
esophagitis, we have examined esophageal tissues using histo-
logical and immunohistochemistry methods. Histopathological 
changes induced by radiation were observed in multiple tissue 
layers of the esophagus, including disruptions in the mucosal 
epithelium, lamina propria, muscularis mucosa and submucosa 
tissue layers. Our studies showed that soy isoflavones reduced 
the extent of damage to the various esophageal tissue layers and 
confirmed a role for soy isoflavones as a complementary and safe 
approach to improve the efficacy of radiotherapy for lung cancer.
MaTerials anD MeThODs
Mice
Female C57BL/6 mice of 5–6 weeks old (Harlan, Indianapolis, IN, 
USA) were housed and handled in animal facilities accredited by 
the Association for Assessment and Accreditation of Laboratory 
Animal Care (AAALAC). Animal protocol was approved by the 
Institutional Animal Care and Use Committee (IACUC).
October 2015 | Volume 5 | Article 2383
Fountain et al. Soy alleviates radiation-induced esophagitis
Frontiers in Oncology | www.frontiersin.org
soy isoflavones
The soy isoflavones mixture G-4660 used is a pure extract of 
98.16% isoflavones from soybeans consisting of 83.3% genistein, 
14.6% daidzein, and 0.26% glycitein (manufactured by Organic 
Technologies and obtained from NIH). The soy isoflavone mix-
ture was dissolved in dimethyl sulfoxide (DMSO) and diluted 
1:20 in sesame seed oil just prior to gavage to avoid irritation of 
the esophagus by DMSO. Mice were orally treated with soy isofla-
vones by gavage. Mice in the control and radiation-alone groups 
received vehicle alone. No toxicity was observed in mice treated 
with soy isoflavones prepared in DMSO and sesame seed oil with 
treatment given 5 days a week by gavage for up to 16 weeks in 
multiple experiments.
Thoracic irradiation
Radiation was delivered at a single dose of 10 Gy or 25 Gy to the 
mouse thorax, including esophagus, bilateral lungs, and medi-
astinum. Three anesthetized mice, in jigs, were positioned under 
a 6.4 mm lead shield with three cut-outs in an aluminum frame 
mounted on the X-ray machine to permit selective irradiation of 
the lung in three mice at a time, as previously described (18–20). 
Radiation dose to the thorax and scattered dose to areas of the 
mouse outside of the radiation field were carefully monitored. 
Dose rate was 101  cGy/min and HVL was 2  mm Cu. Photon 
irradiation was administered using a Siemens Stabilipan X-ray 
set (Siemens Medical Systems, Inc.) operating at 250 kV, 15 mA, 
with 1 mm copper beam filtration at a distance of 47.5 cm from 
the target.
experimental Protocol
Mice were pre-treated with oral soy isoflavones each day for 
3 days at a dose of 5 mg/day (equivalent to 250 mg/kg). On day 4, 
the thorax was selectively irradiated with a dose of 10 Gy or 25 Gy. 
Soy treatment was continued on a daily basis for 5 more days at 
5 mg/day. Then, mice were treated with a lower soy isoflavone 
dose of 1 mg/day (equivalent to 50 mg/kg), given daily 5 days a 
week for up to 16 weeks. The rationale for giving a higher dose 
of soy isoflavones for pre-treatment and just after radiation is to 
optimize the effect of soy based on our previous studies (18–20).
esophageal Tissue Preparation for 
histology
Mice were sacrificed at different time points between 1 and 
16 weeks after irradiation. Esophagi were resected, fixed in 10% 
formalin, and curved into a U shape for embedding in a verti-
cal position in paraffin and transverse tissue sections were cut. 
Esophagus sections were stained with hematoxylin–eosin (H&E) 
and examined using a Nikon E800 microscope. Morphometric 
measurements of inner esophageal tissue layers were performed 
using Image-ProPlus version 6.2 software. The effect of radia-
tion and soy on esophageal layers was evaluated using Masson 
trichrome (MT) stain for detecting collagen fibers. Histological 
findings were quantified using a subjective 4-tiered scale from 
weak (±), moderate (+), strong (++), and heavy (+++). Four 
mice per group were used for data analysis in two series of 
repeated experiments.
immunohistochemistry
Sections of esophagi were stained by immunohistochemistry. 
Sections were blocked with IHC Tek Antibody Diluent, and then 
incubated with primary purified monoclonal antibodies directed 
against α smooth muscle actin (α-SMA) (1:4000), CD45 (1:200), 
and Ki-67 (1:350) followed by biotinylated secondary antibodies 
(1:300). Staining was amplified with the avidin-biotin system 
immunoperoxidase technique. Esophageal layers were examined 
on a Nikon E800 microscope. Four mice per group were used for 
data analysis in two series of repeated experiments.
statistical analysis
Differences in the thickness of inner esophageal tissue layers 
among the various treatment groups were analyzed in four mice 
per group at weeks 4, 10, and 16. To compare the treatment effect 
at each time point, a linear mixed-effects model allowing for 
nested random effects was used (21). A p-value of less than 0.05 
was considered significant. The statistical software R (22) and 
package nlme (23) was used.
resUlTs
soy isoflavones reduce radiation 
Damage to esophageal layers
To assess the effects of irradiation and soy isoflavones on normal 
esophagus, the esophagus was resected at 4, 10, and 16 weeks after 
treatment with either soy alone, radiation alone, or both radia-
tion and soy isoflavones. Esophageal tissues were processed for 
histological examination. Representative images are presented in 
Figure 1. A transverse section of the esophagus shows tissue layers 
lining the lumen and extending into the muscle layers of the mus-
cularis externa (ME, Figure 1, Inset 1). Esophageal tissue layers 
include the mucosae consisting of stratified squamous epithelium 
(EPI), the lamina propria (LP), which is a loose connective tis-
sue, the muscularis mucosae (MM) composed of longitudinally 
organized bundles of smooth muscle fibers, and the submucosa 
(SM) consisting of a thin layer of connective tissue lining the 
muscularis externa (ME) (Figure 1, Inset 2). Because radiation 
caused thickening of LP, MM, and SM, these three layers were 
grouped and defined as inner esophageal layer (IEL) (Figure 1, 
Inset 2). To evaluate the differences in IEL between treatment 
groups, morphometric measurements of IEL were performed 
(Table  1A). At all time points, esophagus from control mice 
showed normal esophageal tissue layer structure and integrity, 
including a healthy mucosal EPI, a thin, dense and continuous LP, 
and small smooth muscle cells within the MM (Figure 1A1,2,3) 
although a gradual increase in IEL measurements was observed 
with time by 4 months (Table 1A). Treatment with soy isoflavones 
did not show alterations in either mucosal EPI or IEL, which were 
comparable to control esophagi (Figure 1B1,2,3; Table 1A). By 
contrast, radiation-treated esophagi showed marked alterations 
in tissue layers that were observed at 4, 10, and 16 weeks after 
radiation. Mucosal EPI showed disruption in the basal cell layer 
alignment, including hyperplasia and hypertrophy of the basal 
cells (see circle in Figure  1C1). Radiation caused progressive 
enlargement of MM, secondary to hypertrophy and vacuolization 
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of smooth muscle cells (arrows in Figure 1C2). The IEL was much 
thicker as seen already at 4 weeks, and further increased at 10- 
and 16-week time points (bracket in Figure 1C3). Morphometric 
measurements confirmed a significant increase in IEL thickness 
compared to control at all time points (p <  0.001, Table  1A). 
Esophagi from mice treated with soy isoflavones before and after 
radiation showed minimal tissue damage with a mucosal EPI and 
IEL comparable to that in normal esophagus (Figure  1D1–3), 
and no significant changes in IEL measurements were observed 
compared to controls (p > 0.1, Table 1A). Soy isoflavones reduced 
the extent of radiation-induced IEL thickening (Figure 1D1–3). 
Measurements of IEL thickness showed that at 10 weeks the IEL 
was significantly smaller in soy + radiation compared to radia-
tion (p < 0.001, Table 1A) and was comparable to control IEL 
(p > 0.05, Table 1A). At time points of 4 and 16 weeks, the IEL was 
marginally yet significantly reduced in radiation + soy compared 
to radiation (p = 0.052–0.053, Table 1A).
soy isoflavones reduce Disruptions of 
lamina Propria connective Tissues 
caused by radiation
Previous studies in our lab showed that soy isoflavones decrease 
the pulmonary fibrosis induced by radiation (18–20). In order 
to evaluate the effect of radiation and/or soy isoflavones on col-
lagen fibers within the LP and SM, tissue sections were stained 
with Masson’s Trichrome. Esophagi from control mice showed 
dense blue, collagen in LP at all time points with few thin wisps 
FigUre 1 | h&e staining of esophagus tissue sections treated with soy, radiation, and soy + radiation. Esophageal tissue sections were obtained from 
control mice and mice treated with soy or radiation (Rad) or soy + radiation (Soy + Rad) at 4, 10, and 16 weeks after radiation. Sections were stained with H&E. 
Inset 1 shows a transverse section of normal esophagus at low magnification (10×). Inset 2 shows esophageal tissue layers starting from the luminal interface, 
including the mucosal epithelium (EPI), lamina propria (LP), muscularis mucosae (MMs), submucosa (SM), and the muscularis externa (ME) (×100). Because lasting 
alterations induced by radiation were observed in LP, MM, and SM, these three layers were grouped as inner esophageal layer (IEL). (a) Sections from control mice 
showing normal morphology of the epithelium and IEL. (B) Sections from mice treated with soy are showing mild changes in IEL and EPI. (c) Esophagi from mice 
treated with radiation, at 4 weeks, showing alterations in the EPI with disruptions in the alignment of epithelial cells and basal cell hyperplasia (circle in 1). In the MM 
layer, consisting of smooth muscle cells, hypertrophy and cytoplasmic vacuolization were observed (arrows in 2). Overall increase in the thickening of IEL and 
extensive vacuolization were observed at 4, 10, and 16 weeks after radiation (brackets in 3). (D) Sections from mice treated with soy + radiation showing 
attenuation in these findings, mostly in LP and MM layers. All magnifications ×100.
TaBle 1 | assessment of histological alterations in esophageal tissues.
Treatment 4 weeks 10 weeks 16 weeks
A. IEL 
thickness 
(mean 
μm ± SEM)
Control
Soy
Radiation
Soy + Rad
15.77 ± 0.40
20.58 ± 0.59
30.66 ± 0.67
25.54 ± 0.67
22.74 ± 0.58
21.80 ± 0.64
41.54 ± 1.18
27.03 ± 0.74
25.13 ± 0.54
30.24 ± 1.08
40.43 ± 0.91
33.28 ± 0.80
B. Collagen 
density in 
LP
Control
Soy
Radiation
Soy + Rad
++
++
+
++
++
++
+
++
++
++
+
++
C. Smooth 
muscle cell 
hypertrophy 
in MM
Control
Soy
Radiation
Soy + Rad
±
±
++
±
±
±
+++
+
±
+
+++
++
(A). Using Image Pro Plus software analysis of H&E slides, morphometric 
measurements of inner esophageal layer (IEL) thickness were performed at 100× 
magnification for each mouse esophagus at 4, 10, and 16 weeks after radiation. 
Data were computed from four representative mice in two separate experiments. Five 
measurements were taken in five random fields per mouse, yielding 25 measurements 
per mouse and 100 measurements for four mice per treatment group, and the 
means ± SEM are reported. (B,C). Histological findings from Masson’s trichrome 
staining for collagen density and smooth muscle cells presented in Figures 2 and 3 
were scored. The extent of collagen density within the lamina propria (LP) and smooth 
muscle cell hypertrophy of the muscularis mucosae (MMs) were scaled from weak (±), 
moderate (+), strong (++), to heavy (+++).
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in SM (circles in Figure 2A1–3). Similar findings were seen in 
mice treated with soy isoflavones alone (circles Figure 2B1–3). 
Irradiated esophagi revealed that the density of collagen fibers 
was reduced in the LP at 4  weeks (circle in Figure  2C1) and 
collagen fibers were seen infiltrating into MM layer at 10 and 
16 weeks (arrows in Figure 2C2,3). Esophagi from mice treated 
with irradiation and soy isoflavones showed increased collagen 
density in LP, and reduced infiltration of collagen in the MM. 
These findings were comparable to that of control and soy isofla-
vone treated mice, predominately at 4 and 10 weeks after radiation 
(Figure 2D1–3). Assessment of alterations in LP collagen density 
is scored and provided in Table 1B.
soy isoflavones Decrease smooth Muscle 
cell Destruction induced by radiation
H&E staining and Masson’s Trichrome stain of esophagus 
tissues showed hypertrophy and vacuolization of smooth 
muscle cells in MM. In order to evaluate smooth muscle cell 
hypertrophy within the MM tissue layer, IHC staining with 
αSMA was performed. Comparable MM thickness in control 
and soy-treated mice was seen with a slight increase in MM 
thickness over time (Figures  3A,B1–3). Following  radiation, 
IHC confirmed H&E findings with hypertrophied large 
smooth muscle cells showing cytoplasmic vacuolization at all 
time points (circles in Figure 3C1,3). Additionally, irradiated 
esophagi showed discontinuity within the MM layer (arrows 
in Figure  3C2). Esophagi from mice treated with combined 
radiation and soy isoflavones showed reduced smooth muscle 
cell hypertrophy, with cell size comparable to control, and lim-
ited fragmentation of MM smooth muscle throughout all time 
points after radiation treatment (Figure 3D1,2,3). Assessment 
of alterations in MM smooth muscle cell hypertrophy is scored 
in Table 1C.
soy isoflavones reduce leukocytic 
infiltration Within esophageal Tissue 
layers after radiation
To evaluate inflammatory infiltration induced by radiation and 
the effect of soy isoflavones, esophageal tissue sections, obtained 
at 4 weeks, were stained by IHC using the pan-leukocyte CD45 
marker. Esophagi from untreated mice and mice treated with 
soy isoflavones showed a normal distribution of CD45 + leuko-
cytes scattered within the IEL layers (Figures 4A,B). Irradiated 
esophagus tissues showed a major infiltration of CD45 + leuko-
cytes in all layers of IEL often organized in focal clusters (arrows 
Figure 4C2). Esophagi treated with radiation and soy isoflavones 
showed much lower levels of CD45+ cell infiltrates comparable to 
those of control and soy-treated esophagus (Figure 4D1,2). These 
data were reproducible and observed in four mice per treatment 
group.
soy isoflavones Mitigate early effects of 
radiation-induced Damage on the 
Mucosal epithelium
We have described the histopathological changes occurring in 
response to radiation, and mitigation by soy isoflavones at 4 to 
16 weeks after radiation treatment and at a single dose of 10 Gy 
radiation. The effects of soy isoflavones at an early time point after 
radiation and at a higher dose of radiation were tested to determine 
whether alterations caused by radiation can be detected earlier 
and are exacerbated by a higher radiation dose. Esophageal tissue 
sections, stained with H&E or Ki-67, were evaluated at 1 week 
after radiation from mice receiving either 10 Gy or 25 Gy irra-
diation alone or in combination with soy isoflavones. Untreated 
esophagi showed normal tissue layers at 1 week after radiation 
(Figure 5A1) and active proliferation of mucosal epithelial cells 
(5A2). Esophagi from mice treated with soy isoflavones showed 
normal, undisturbed tissue layers with dividing epithelial cells, 
similar to control (Figure 5B1,2). As previously shown at later 
time points (Figure 1C), increased thickening of the IEL (bracket 
in 5C2) and disruptions in the continuity of mucosal basal cells 
were already observed at 1  week after 10 and 25  Gy radiation. 
The number of dividing epithelial cells was markedly reduced by 
10 Gy (Figure 5C2) while 25 Gy not only showed a paucity of 
normal size dividing epithelial cells but showed major alterations 
with apoptotic keratinocytes (Figure 5B1), enlarged and hyper-
plastic cells with large dividing nuclei probably due to formation 
of degenerating giant cells, characteristic of radiation effects 
(Figure  5D1,2). By contrast, esophagi from mice treated with 
radiation and soy isoflavones showed limited alterations in basal 
cell morphology and size with no disruption in the alignment 
along the basement membrane, and reduced thickening of IEL 
(Figures 5E,F,1). Soy isoflavones improved epithelial cell division 
(Figure 5E2); however, at 25 Gy, some areas still showed some 
enlarged, dividing cells (Figure 5F2). These data were reproduc-
ible and observed in four mice per treatment group.
FigUre 2 | effect of soy and radiation on connective tissue layers of esophagus. Esophageal sections obtained from the experiments described in Figure 1 
were stained with Masson’s Trichrome for detection of collagen fibers within the LP and SM connective tissues. Insets 1 and 2 show normal esophagi with collagen 
staining in LP and SM below the negative staining of MM. (a) Sections from control mice showed similar collagen fibers distribution limited to LP and SM as labeled 
in A1. (B) Sections from mice treated with soy showed staining patterns comparable to controls. (c) Sections from mice treated with radiation showed disruptions in 
the LP (labeled in C1) and infiltration of collagen fibers focally into the MM with entrapment of hypertrophic smooth muscle cells (arrows in C2). (D) Sections from 
mice treated with soy + radiation showed reduced collagen infiltration into MM smooth muscle compared to radiation and a higher density of fibers (labeled in D1) 
that is comparable to LP of control and soy-treated esophagus. All magnifications ×100.
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DiscUssiOn
For NSCLC patients, radiation-induced esophagitis presents a 
major radiation dose-limiting challenge to radiation oncologists 
may result in dehydration, malnutrition, and even disruption of 
the treatment course (1–5). Nearly all patients experience some 
level of esophageal toxicity within the field of their radiation 
treatment, and present with varying severity of odynophagia and 
dysphagia as a result of tissue injury and inflammation, neces-
sitating the need for intervention with effective therapeutics.
We have previously reported the radioprotective effect of 
soy isoflavones for lung tissue in lung tumor bearing mice and 
in naïve mice, mitigating radiation-induced pneumonitis and 
pulmonary fibrosis (18–20). To further investigate whether soy 
isoflavones could protect other thoracic organs in the field of 
radiation for NSCLC, in particular the esophagus, we have now 
explored the effect of radiation alone given at a single high dose 
of 10 Gy and combined with soy isoflavone supplementation on 
esophageal tissue layers. In an early response to radiation, the 
esophagus undergoes extensive tissue edema (12), which is a 
hallmark of radiation-induced tissue damage which has also been 
documented in other organs, including lung EPI and gut mucosa 
(24–26). Radiation produces a cyclic, chronic inflammatory 
response, which includes the deposition of collagen and reconsti-
tution of extracellular matrix compartments (25, 27). Prolonged 
accumulation of collagen and extracellular matrix components 
explains long-term development of esophageal strictures, occur-
ring months to years after radiation treatment (1, 2, 12, 27).
In the current pre-clinical study, major alterations in esopha-
geal tissue layers caused by radiation injury were observed at 
both early and late time points up to 4 months after radiation. 
In particular, thickening of the IELs was observed from 4 to 
FigUre 3 | effect of soy and radiation on smooth muscle cells in muscularis mucosae (MMs). Esophagus tissue sections obtained from the experiments 
described in Figure 1 were stained with anti-αSMA by IHC for detection of smooth muscle cells in MM. Insets 1 and 2 show a low and high power view of normal 
esophagus highlighting MM. (a) Sections from control mice and (B) sections from mice treated with soy showed comparable morphology and thickening of MM. (c) 
αSMA staining confirmed thickening of LP and MM caused by radiation and smooth muscle cell enlargement (circles in C.1), large empty vacuoles, and 
condensation of nuclei in MM (circles in C3). Interruptions in the integrity of MM layer were also observed (arrows in C.2). (D) Sections from mice treated with 
soy + radiation showed reduced smooth muscle cell hypertrophy and limited disintegration of MM compared to radiation alone. All magnifications ×100.
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16 weeks after radiation. The edematous response of esophageal 
tissues is well documented and esophageal swelling can be con-
sidered a contributor to dysphagia caused by radiation treatment, 
as suggested by endoscopy studies in patients (12). In our mouse 
studies, increased thickness of IEL layers following radiation 
was significantly reduced by complementing radiation with soy 
isoflavones, suggesting that soy isoflavones could limit the extent 
of tissue damage caused by radiation.
To analyze histopathological changes within the various tis-
sues of the IEL, specific histological staining showed that radia-
tion caused alterations in the esophageal connective tissue layers. 
Decreased density and altered distribution of collagen fibers were 
seen in the LP as well as infiltration of collagen fibers between 
hypertrophied smooth muscle cells in MMs. These altera-
tions could be early events of the process of radiation-induced 
fibrosis. Fibrosis is a remodeling process to repair tissue damage 
by deposition of collagen and extracellular matrix into sites of 
damaged or necrotic tissue. (25, 27) Fibrotic accumulation of 
collagen over long periods of time – months to years – can lead 
to esophageal stricture formation and can cause dysphagia, a 
chronic symptom from radiation (1, 2, 12). Soy isoflavones 
showed a protective role on maintaining the density and integrity 
of collagen fibers in esophageal connective tissues and could play 
a role in decreasing the progression of long-term stricture forma-
tion as a result of radiation-induced fibrosis.
Specific staining of smooth muscle cells forming the MMs layer 
showed that these cells were sensitive to radiation resulting in 
hypertrophy, vacuolation, and cell death, leading to interruptions 
in the integrity of the MMs. This effect was seen at 4 weeks and 
persisted up to 16 weeks after radiation. However, smooth muscle 
cell disruption was reduced in tissues with combined treatment 
of radiation and soy isoflavones at all time points. Smooth muscle 
FigUre 4 | leukocyte infiltration in esophageal tissues treated with soy and radiation. Esophagi tissue sections were obtained from control mice and mice 
treated with soy or radiation (Rad) or soy + radiation (Soy + Rad) at 4 weeks after radiation. Sections were stained with anti-CD45 by IHC for detection of leukocytes 
in IEL. [(a) 1,2] Sections from control mice showed scattered CD45+ cells within the IEL layers. [(B) 1,2)] Similar distribution of CD45+ leukocytes in mice treated 
with soy compared to control. [(c) 1,2)] Sections from mice treated with radiation showing a prominent infiltration of CD45+ leukocyte infiltration in all layers of IEL 
(arrows in C2). [(D) 1,2] Sections from mice treated with soy + radiation with much lower levels of CD45+ cell infiltrates comparable to those of control and 
soy-treated esophagus. (magnifications ×40 for A1, B1, C1, D1; and ×100 for A2, B2, C2, D2).
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damage and loss in response to radiation have been observed in the 
walls of vessels and capillaries and are involved in vascular disrup-
tion (25). But specific studies investigating the pathological events 
related to smooth muscle cell destruction from radiation injury 
remain limited. Preservation of smooth muscle cell structure by soy 
isoflavones, both at the cellular level by reducing hypertrophy, and at 
the tissue level by reducing fragmentation, could provide functional 
conservation of MMs smooth muscle, limiting the development 
and progression of radiation-induced dysphagia in a clinical setting.
Inflammatory cell infiltration is known to be a normal response 
by various tissues to radiation injury in conjunction with tissue 
edema (25, 27, 28). In the esophagus, radiation caused a promi-
nent infiltration of leukocytes in the IEL, but this process was 
limited when soy isoflavones were supplemented to radiation. 
Reduced inflammatory infiltrates were also documented in lungs 
treated with radiation and soy isoflavones in our previous studies 
(18–20). Further studies are ongoing to investigate the effect of 
soy isoflavones on mitigating the inflammatory response induced 
by radiation in normal tissues.
Finally, acute effects of radiotherapy on the esophagus involve 
sloughing of superficial layers of the squamous EPI in human 
studies (12). In mouse studies, we found that radiation injury 
to the mucosal EPI included disruptions in the basal cell layer 
alignment with hypertrophy of epithelial cells. Epithelial cell 
depletion, apoptotic keratinocytes, and abnormal giant cells with 
large nuclei were more pronounced with a higher single dose of 
25 Gy irradiation, and were seen already at 1 week after radiation 
as confirmed by staining with Ki-67 proliferative marker. The 
regular arrangement of basal cells depend on intracellular tight 
junctions, which hold cells together and are the basis for maintain-
ing mucosal tissue barrier functions (29). Soy isoflavones given 
in conjunction with radiation appeared to preserve the integrity 
of the basal cell layer of the mucosal EPI and fewer abnormal 
epithelial cells at both single doses of 10 and 25 Gy radiation at 
early and late time points. Soy isoflavones could therefore provide 
maintenance of mucosal barrier function and limit the depletion 
of the mucosal EPI, improving radiation-induced odynophagia. 
Indeed, in support of our findings, a review examining the role 
of flavonoids in intestinal tight junction regulation showed that 
genistein, the most bioactive isoflavone found in soy, protected 
intestinal tight junction barrier function by counteracting the 
disassembly of occludins induced by oxidative stress and acetylal-
dehyde (30). Other studies reported the role of genistein in reduc-
ing apoptosis induction in normal seminiferous tubule mucosal 
tissues (31) and intestinal mucosal tissues (32) in agreement with 
the effect of soy isoflavones in mitigating the effect of radiation 
damage on mucosal EPI in the esophagus. As strategies to allevi-
ate esophagitis, phase II and III trials of amifostine, an organic 
thiophosphate and potent scavenger of oxygen free radicals, have 
shown mixed results in reducing esophagitis while causing nau-
sea and vomiting in patients (9). By contrast, soy isoflavones have 
been shown to be safe natural compounds in all of our murine 
studies as well as in humans in controlled clinical trials (33).
Taken together, our study shows that soy isoflavones provide 
a radioprotective role by reducing radiation-induced damage 
to various tissue layers in the esophagus when radiation was 
FigUre 5 | early effects of soy on esophageal tissues treated with 25 gy radiation compared to 10 gy radiation. Esophagi were obtained from control 
mice and mice treated with soy or radiation (Rad) or soy + radiation (Soy + Rad) at 1 week after a radiation dose of 10 or 25 Gy. Sections were stained with H&E 
(series 1) and Ki-67 (series 2). Sections from control mice (a) and sections from mice treated with soy (B) both showed normal morphology and active proliferation 
of mucosal epithelial cells. (c) Sections from mice treated with 10 Gy radiation showed enlargement of IEL and disruptions in basal cell basement membrane 
continuity (dotted lines in C.1) and decreased proliferation (C.2). (D) A higher dose of 25 Gy radiation caused greater alterations in the EPI mucosal layer, including 
basal cell hyperplasia, enlargement of epithelial cells (circles in D.1), and apoptotic keratinocytes in the parabasal layer (arrows in D.1). Ki-67+ cells showed staining 
of large nuclei but an overall decrease in the number of dividing cells (D.2). (e,F) Sections from mice receiving combined treatment of 10 or 25 Gy radiation with soy 
showed decreased alterations in mucosal basal cell morphology and size, improved basal cell division, and decreased thickening of the IEL.
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delivered as a single high dose. Further studies are ongoing to 
compare the histopathology of single high dose to fractionated 
radiation and the effect of soy isoflavones. In a recent preliminary 
experiment, soy isoflavones also reduced alterations in esopha-
geal tissues in mice receiving fractionated radiation and cisplatin 
which had greater damage in esophageal tissues by radiation and 
cisplatin compared to radiation alone. These findings suggest 
that soy isoflavones could mediate radioprotection in a murine 
model of concurrent chemoradiation, which is known to cause 
greater acute esophagitis in NSCLC patients. It is possible that 
the beneficial radioprotective effect of soy isoflavones at the histo-
logical level would translate also into a beneficial functional effect 
on esophageal motility and be integrated in clinical protocols 
to mitigate the harmful side effects of radiation. To this effect, 
we are currently conducting a Phase I clinical trial to evaluate 
the safety and efficacy of soy supplementation to conventional 
chemoradiotherapy for advanced stage III NSCLC disease.
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